Jill Sollenberger

Jill Sollenberger is an experienced professional in the pharmaceutical and biopharmaceutical industries, currently serving as the Head of Research and Early Development Quality Operations at UCB since May 2017. Responsibilities include providing quality support for early solutions R&D activities and managing operational oversight of GLP test facility activities and human tissue regulations in Belgium and the UK, along with leading a team of preclinical QA auditors. Previous roles at UCB involved serving as Preclinical Quality Lead and Global Quality Lead, focusing on compliance and vendor qualification audits. Prior positions at Catalent Pharma Solutions, MSD, GSK, and Targacept, Inc. provided expertise in quality assurance, drug product development, analytical chemistry, and research methodologies. Jill holds an MRes in Chemistry from the University of Nottingham and a BS in Biochemistry from the University of North Carolina at Greensboro.